Article

Evaluation of neutralizing antibodies produced by papaya mosaic virus nanoparticles fused to the E2EP3 peptide epitope of Chikungunya envelope

2020-03-02

Abstract excerpt

Chikungunya virus (CHIKV) infection is the cause of acute symptoms and chronic symmetrical polyarthritis associated with long-term morbidity and mortality. Currently, there is no available licensed vaccine or particularly useful drug for human use against CHIKV infection. This study was conducted to evaluate the efficacy of antibodies produced by papaya mosaic virus (PapMV) nanoparticles fused to E2EP3 peptide of...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d1792e18-1b9a-562c-aba1-7cee7a0b79d7
DOI: 10.1101/2020.02.28.970657

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Evaluation of neutralizing antibodies produced by papaya mosaic virus nanoparticles fused to the E2EP3 peptide epitope of Chikungunya envelopeDOI 10.1101/2020.02.28.970657Read

Chikungunya virus vaccine: a decade of progress solving epidemiological dilemma, emerging concepts, and immunological interventionsSemantic proximity Read

Expression and Characterization of Yeast Derived Chikungunya Virus Like Particles (CHIK-VLPs) and Its Evaluation as a Potential Vaccine CandidateSemantic proximity Read

Antibody-based therapeutic interventions: possible strategy to counter chikungunya viral infection.Semantic proximity Read

mRNA Vaccine Designing Using Chikungunya Virus E Glycoprotein through Immunoinformatics-Guided ApproachesSemantic proximity Read

Evolution and immunopathology of chikungunya virus informs therapeutic development.Semantic proximity Read

Subunit vaccine formulations based on recombinant envelope proteins of Chikungunya virus elicit balanced Th1/Th2 response and virus-neutralizing antibodies in miceSemantic proximity Read

Chimeric chikungunya virus-like particles with surface exposed SARS-CoV-2 RBD elicits potent immunogenic responses in miceSemantic proximity Read

The Safety and Efficacy of the Chikungunya Virus Vaccine: A Systematic Review and Meta Analysis.Semantic proximity Read

Construction and immunogenicity of an mRNA vaccine against chikungunya virusSemantic proximity Read

Safety and immunogenicity of a virus-like particle Chikungunya virus vaccineSemantic proximity Read

Assessment of immunogenic potential of Vero adapted formalin inactivated vaccine derived from novel ECSA genotype of Chikungunya virus.Semantic proximity Read

Isolation and characterization of high affinity and highly stable anti-Chikungunya virus antibodies using ALTHEA Gold Libraries™Semantic proximity Read